Ovel 0.5% Eye Drops 5ml

Ovel eye drops are indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following bacteria:

• Aerobic Gram-Positive bacteria: Corynebacterium species, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Streptococcus (Groups C/F), Streptococcus (Group G), Streptococcus viridons group.
• Aerobic Gram-Negative bacteria: Acinetobacter iwoffii, Haemophilus influenzae, Serrotia morcescens.
• Ovel also provides a promising treatment for other ocular infections including- Bacterial corneal ulcer, Blepharitis, Hordeolum & Perioperative condition.

Specific drug interaction studies have not been conducted with Ovel eye drops. But the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives.

It is contraindicated in patients with a history of hypersensitivity to Levofloxacin, to other quinolones, or to any of the components of this medication

Side effects occurred only in approximately 1-3% of patients and may include transient blurred vision, fever, foreign body sensation, headache, transient ocular burning, ocular pain or discomfort, pharyngitis, and photophobia. In less than 1% of patients included allergic reactions, lid edema, ocular dryness and ocular itching.

Pregnancy Category C. Levofloxacin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Levofloxacin has not been measured in human milk. Caution should be exercised when Levofloxacin eye drops are administered to a nursing mother.

Prolonged use may result in the overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.

Eye drops should be protected from light; store in a cool (15°-25° C) and dry place & keep out of reach of children.